• Icon International Neuroendocrine Cancer Alliance

  • Mail: post@incalliance.org

Tag: Paediatric Pituitary Tumours in MEN1

DoLUPXMXkAAn5W7
AMEND Is Working With ENDO ERN to Improve Access to Gold Standard Treatment

AMEND is working with the European Reference Network for Rare Endocrine Conditions (ENDO ERN) to help widen access to gold standard treatment throughout Europe.  During the European Society for Paediatric Endocrinology (ESPE) conference in Athens, AMEND CEO, Jo Grey was invited to speak in the ENDO ERN Symposium on Paediatric Pituitary Tumours in MEN1.  These…

Read More
Copyright © 2015 International Neuroendocrine Cancer Alliance. All right reserved.
Make a Donation
Paybal button